Therapeutics case studies
How we maximise the value of our clients' development approach while reducing costs and timelines
Learn more on how we bring life changing therapies to market.
Providing empirically based guidance and built-to-spec models and solutions across every phase of clinical research and lifecycle management for therapeutic development.
Human Cytomegalovirus Vaccine Development
A pharmaceutical client needed to better understand patient perspectives, concerns and awareness of that could impact the development of a vaccine for Human Cytomegalovirus (HCMV).
H1N1 vaccine study
A sponsor approached ICON during an influenza pandemic in Mexico to conduct a randomised, placebo controlled vaccine study with an investigative pandemic H1N1 vaccine.
Rapid mobilisation to advance COVID-19 vaccine development
COA Repository, revolutionizing the management of COAs within the sponsor’s clinical trials.
.jpg?crop=yes&w=2048&h=1077&a=0,145&itok=kNn5Nd_T "Accellacare staff providing care"){kind=icon}
Exceeding expectations in a c. diff vaccine study
Five Accellacare sites were selected to participate in a clostridium difficile (c. diff) vaccine study being conducted
by a large pharma sponsor and ICON.
by a large pharma sponsor and ICON.